Posted by Michael Wonder on 02 Oct 2020
HHS says Gilead, distributor can directly sell COVID-19 drug in U.S.
1 October 2020 - The U.S. Department of Health and Human Services said on Thursday that U.S. hospitals can now buy Gilead Sciences' anti-viral COVID-19 drug remdesivir from the company and its distributor.
The medicine, branded as Veklury, was being distributed across the United States by Health and Human Services.
Gilead said it is now meeting real-time demand for remdesivir in the U.S. and anticipates meeting global demand for the drug in October, even in the event of potential future surges of COVID-19.
